Summary Financial Statements Independent Auditors Statement to the members of Smith & Nephew plc We have examined the Groups Summary Financial Statements for the year ended 31 December 2009 which comprises Group Income Statement, Condensed Group Statement of Comprehensive Income, Group Balance Sheet, Condensed Group Cash Flow Statement and Statement of Changes in Equity and the related Notes 1 to 11.
This report is made solely to the Companys members, as a body, in accordance with Section 428 a of the Companies Act 2006.
Our audit work has been undertaken so that we might state to the Companys members those matters we are required to state to them in an auditors statement and for no other purpose.
To the fullest extent required by law, we do not accept or assume responsibility to anyone other than the Company and the Companys members as a body, for our audit work, for this statement, or for the opinions we have formed.
Respective responsibilities of directors and auditors The directors are responsible for preparing the Summary Financial Statement in accordance with applicable United Kingdom law.
Our responsibility is to report to you our opinion on the consistency of the Summary Financial Statement with the full annual accounts, the directors report and directors remuneration report, and its compliance with the relevant requirements of section 428 of the Companies Act 2006 and the regulations made thereunder.
We also read the other information contained in the Summary Financial Statement and consider the implications for our report if we become aware of any apparent misstatements or material inconsistencies with the Summary Financial Statement.
We conducted our work in accordance with Bulletin 2008 3 issued by the Auditing Practices Board.
Our report on the Companys full annual accounts describes the basis of our opinion on those accounts, the directors report and the directors remuneration report.
Opinion In our opinion the Summary Financial Statement is consistent with the full annual accounts, the directors report and directors remuneration report of Smith & Nephew plc for the year ended 31 December 2009 and complies with the applicable requirements of section 428 of the Companies Act 2006, and regulations made thereunder.
Ernst & Young LLP Statutory Auditor London, England 18 March 2010 The maintenance and integrity of the Smith & Nephew plc web site is the responsibility of the directors: the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the Annual Report and Summary Financial Statement since it was initially presented on the web site.
Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
15 Smith & Nephew Summary Annual Review 2009 Summary Shareholder Summary Financial Outlook Business Reviews Financial Performance Our Strategy Financial Highlights Introduction Information Statements Remuneration Report Summary Financial Statements Group Income Statement for the year ended 31 December 2009 2009 2008 Notes $ million $ million Revenue 3 3,772 3,801 Cost of goods sold 1,030 1,077 Gross profit 2,742 2,724 Selling, general and administrative expenses 1,864 1,942 Research and development expenses 155 152 Operating profit 4 723 630 Interest receivable 2 5 Interest payable 42 71 Other finance costs 15 1 Share of results of associates 2 1 Profit before taxation 670 564 Taxation 7 198 187 Attributable profit for the year a 472 377 Earnings per share a Basic 53.4 42.6 Diluted 53.3 42.4 Condensed Group Statement of Comprehensive Income for the year ended 31 December 2009 2009 2008 $ million $ million Attributable profit 472 377 Other comprehensive income: Translation adjustments 60 99 Net gains on cash flow hedges 2 4 Actuarial gains losses on defined benefit pension plans 41 215 Taxation on items relating to components of other comprehensive income 12 71 Other comprehensive income expense for the period, net of tax 91 239 Total comprehensive income for the period a 563 138 a Attributable to the equity holders of the parent and wholly derived from continuing operations.
16 Smith & Nephew Summary Annual Review 2009 Summary Shareholder Summary Financial Outlook Business Reviews Financial Performance Our Strategy Financial Highlights Introduction Information Statements Remuneration Report Summary Financial Statements Group Balance Sheet as at 31 December 2009 2009 2008 $ million $ million ASSETS Non-current assets Property, plant and equipment 753 725 Goodwill 1,093 1,189 Intangible assets 412 376 Investments 7 7 Investments in associates 13 12 Deferred tax assets 202 214 2,480 2,523 Current assets Inventories 933 879 Trade and other receivables 946 961 Cash and bank 192 145 2,071 1,985 Assets held for disposal 14 - TOTAL ASSETS 4,565 4,508 EQUITY AND LIABILITIES Equity attributable to equity holders of the parent Share capital 190 190 Share premium 382 375 Treasury shares 794 823 Other reserves 63 1 Retained earnings 2,338 1,956 Total equity 2,179 1,699 Non-current liabilities Long-term borrowings 1,090 1,358 Retirement benefit obligations 322 350 Other payables due after one year 27 36 Provisions due after one year 53 51 Deferred tax liabilities 31 46 1,523 1,841 Current liabilities Bank overdrafts and loans due within one year 45 115 Trade and other payables due within one year 596 607 Provisions due within one year 55 54 Current tax payable 167 192 863 968 Total liabilities 2,386 2,809 TOTAL EQUITY AND LIABILITIES 4,565 4,508 17 Smith & Nephew Summary Annual Review 2009 Summary Shareholder Summary Financial Outlook Business Reviews Financial Performance Our Strategy Financial Highlights Introduction Information Statements Remuneration Report Summary Financial Statements Condensed Group Cash Flow Statement for the year ended 31 December 2009 2009 2008 Notes $ million $ million Net cash inflow from operating activities Profit before taxation 670 564 Net interest payable 40 66 Depreciation, amortisation and impairment 312 287 Share based payment expense 18 24 Utilisation of Plus inventory stepped-up on acquisition - 15 Share of results of associates 2 1 Movement in working capital and provisions 8 140 Cash generated from operations b 1,030 815 Net interest paid 41 63 Income taxes paid 270 186 Net cash inflow from operating activities 719 566 Cash flows from investing activities Acquisitions 25 16 Cash received from Plus settlement 8 137 - Capital expenditure 318 289 Net cash used in investing activities 206 305 Cash flows from financing activities Proceeds from issue of ordinary share capital 7 19 Purchase of treasury shares - 193 Cash movements in borrowings 354 31 Settlement of currency swaps 12 5 Proceeds from own shares 10 4 Equity dividends paid 120 109 Net cash used in financing activities 469 243 Net increase in cash and cash equivalents 44 18 Cash and cash equivalents at beginning of year 122 109 Exchange adjustments 8 5 Cash and cash equivalents at end of year c 174 122 b After $22 million 2008 $48 million of acquisition related costs and $32 million 2008 $28 million of outgoings on restructuring and rationalisation expenses.
c Cash and cash equivalents at the end of the year are net of overdrafts of $18 million 2008 $23 million.
18 Smith & Nephew Summary Annual Review 2009 Summary Shareholder Summary Financial Outlook Business Reviews Financial Performance Our Strategy Financial Highlights Introduction Information Statements Remuneration Report Summary Financial Statements Statement of Changes in Equity for the year ended 31 December 2009 Share Share Treasury Other Retained Total capital premium shares reserves earnings equity $ million $ million $ million $ million $ million $ million At 1 January 2008 190 356 637 96 1,811 1,816 Total comprehensive income - - - 95 233 138 Equity dividends accrued and paid - - - - 109 109 Share based payment recognised - - - - 24 24 Treasury shares purchased - - 193 - - 193 Cost of shares transferred to beneficiaries - - 7 - 3 4 Issue of ordinary share capital - 19 - - - 19 At 1 January 2009 190 375 823 1 1,956 1,699 Total comprehensive income - - - 62 501 563 Equity dividends accrued and paid - - - - 120 120 Share based payment recognised - - - - 18 18 Deferred tax on share based payment - - - - 2 2 Cost of shares transferred to beneficiaries - - 29 - 19 10 Issue of ordinary share capital - 7 - - - 7 At 31 December 2009 190 382 794 63 2,338 2,179 19 Smith & Nephew Summary Annual Review 2009 Summary Shareholder Summary Financial Outlook Business Reviews Financial Performance Our Strategy Financial Highlights Introduction Information Statements Remuneration Report Summary Financial Statements Notes to the Summary Financial Statements 1.
The Summary Financial Statements have been derived from the Consolidated Financial Statements of Smith & Nephew plc and its subsidiaries collectively known as the Group.
The financial information contained herein has been prepared on the basis of the accounting policies as set out in the annual accounts of the Group for the year ended 31 December 2009.
The Group prepares its annual accounts on the basis of International Financial Reporting Standards IFRS as issued by International Accounting Standards Board IASB, IFRS as adopted by the European Union EU and in accordance with the provisions of the Companies Act 2006.
IFRS as adopted by the EU differs in certain respects from IFRS as issued by the IASB.
However, the differences have no impact for the periods presented.
Adjusted earnings per ordinary share EPSA is a trend measure which presents the long-term profitability of the Group excluding the impact of specific transactions that management considers as affect the Groups short-term profitability.
The Group presents this measure to assist investors in their understanding of trends.
Adjusted attributable profit is the numerator used for this measure.
EPSA has been calculated by dividing adjusted attributable profit by the weighted basic average number of ordinary shares in issue of 884 million 2008 886 million.
The diluted weighted average number of ordinary shares in issue is 885 million 2008 890 million.
2009 2008 Notes $ million $ million Attributable profit for the year 472 377 Acquisition related costs 6 26 61 Restructuring and rationalisation costs 5 42 34 Amortisation of acquisition intangibles and impairments 10 66 51 Taxation on excluded items 7 26 30 Adjusted attributable profit 580 493 Adjusted basic earnings per ordinary share 65.6 55.6 Adjusted diluted earnings per ordinary share 65.5 55.4 20 Smith & Nephew Summary Annual Review 2009 Summary Shareholder Summary Financial Outlook Business Reviews Financial Performance Our Strategy Financial Highlights Introduction Information Statements Remuneration Report Summary Financial Statements 3.
Revenue by segment for the year to 31 December 2009 was as follows: Underlying 2009 2008 growth in $ million $ million revenue % Revenue by operating segment Orthopaedics 2,135 2,158 1 Endoscopy 791 800 1 Advanced Wound Management 846 843 6 3,772 3,801 2 Revenue by geographic market United States 1,664 1,657 - Europe d 1,313 1,398 1 Africa, Asia, Australasia & Other America 795 746 8 3,772 3,801 2 d Includes United Kingdom revenue of $286 million 2008 $321 million.
Underlying revenue growth by operating segment is calculated by eliminating the effects of translational currency.
Reported growth reconciles to underlying growth as follows: Reported Constant currency Underlying growth in revenue % exchange effect % growth in revenue % Orthopaedics 1 2 1 Endoscopy 1 2 1 Advanced Wound Management - 6 6 1 3 2 21 Smith & Nephew Summary Annual Review 2009 Summary Shareholder Summary Financial Outlook Business Reviews Financial Performance Our Strategy Financial Highlights Introduction Information Statements Remuneration Report Summary Financial Statements 4.
Trading profit is a trend measure which presents the long-term profitability of the Group excluding the impact of specific transactions that management considers as affect the Groups short-term profitability.
Operating profit reconciles to trading profit as follows: 2009 2008 Notes $ million $ million Operating profit 723 630 Acquisition related costs 6 26 61 Restructuring and rationalisation expenses 5 42 34 Amortisation of acquisition intangibles and impairments 10 66 51 Trading profit 857 776 Trading and operating profit by business segment for the year to 31 December 2009 were as follows: 2009 2008 $ million $ million Trading profit by business segment Orthopaedics 508 481 Endoscopy 189 166 Advanced Wound Management 160 129 857 776 2009 2008 $ million $ million Operating profit by business segment Orthopaedics 410 382 Endoscopy 169 146 Advanced Wound Management 144 102 723 630 5.
Restructuring and rationalisation costs comprise $42 million 2008 $34 million relating to the earnings improvement programme and mainly comprise of costs associated with the rationalisation of operational sites.
Acquisition related costs comprise $26 million relating to Plus integration 2008 $46 million.
For 2008, the costs include a $15 million relating to the utilisation of the Plus inventory stepped-up to fair value on acquisition.
22 Smith & Nephew Summary Annual Review 2009 Summary Shareholder Summary Financial Outlook Business Reviews Financial Performance Our Strategy Financial Highlights Introduction Information Statements Remuneration Report Summary Financial Statements 7.
Taxation of $224 million 2008 $217 million for the year on the profit before restructuring and rationalisation costs, acquisition related costs and amortisation of acquisition intangibles and impairments is at the full year effective rate o f 27.9% 2008 30.6%.
In 2009, a taxation benefit of $26 million 2008 - $30 million arose on restructuring and rationalisation costs, acquisition related costs and amortisation of acquisition intangibles and impairments.
Of the $198 million 2008 - $187 million taxation charge for the year, $174 million 2008 - $144 million relates to overseas taxation.
On 31 May 2007, the Group completed the acquisition of Plus Orthopedics Holding AG Plus, a private Swiss orthopaedic company for a total of CHF1,086 million $889 million in cash, including assumed debt.
This has been integrated into the Groups Orthopaedics business segment.
In January 2009, the Group reached an agreement with the vendors of Plus to reduce the total original purchase price by CHF159 million.
As part of the agreement, the Group dropped all its claims and released the vendors from substantially all of the remaining warranties under the original purchase agreement, as well as resolving the contractual purchase price adjustments.
The 2009 first interim dividend of $48 million being 5.46 US cents per ordinary share was paid on 3 November 2009.
A second interim dividend for 2009 of 8.93 US cents per ordinary share has been declared by the Board and will be payable on 12 May 2010 to shareholders whose names appear on the register at the close of business on 23 April 2010.
The Sterling equivalent per ordinary share will be set following the record date.
Shareholders may elect to receive their dividend in either Sterling or US Dollars and the last day for election will be 23 April 2010.
Shareholders may participate in the dividend re-investment plan.
With effect from 2010, ADS holders will be charged a dividend fee of up to 2.0 US cents per ADS per dividend payment.
The fee is being implemented to offset some of the costs associated with administering the ADS facility and other expenses associated with a US listing.
It is expected that a fee of 2.0 US cents will be deducted from the 2009 second interim dividend payment in May 2010 and a fee of 1.0 US cent will be deducted from the 2010 first interim dividend payment as and when declared and paid.
During Quarter Four the Group incurred $32 million 2008 - $14 million of impairment charges against goodwill and certain intangible assets arising from the acquisition of the pain management business and OsteoBiologics Inc.
This charge has been reported within the selling, general and administrative expenses line in the income statement.
In the reconciliation of operating profit to trading profit, this charge is reported within amortisation of acquisition intangibles and impairments.
23 Smith & Nephew Summary Annual Review 2009 Summary Shareholder Summary Financial Outlook Business Reviews Financial Performance Our Strategy Financial Highlights Introduction Information Statements Remuneration Report Summary Financial Statements 11.
Net debt as at 31 December comprises: 2009 2008 $ million $ million Cash and bank 192 145 Long-term borrowings 1,090 1,358 Bank overdrafts and loans due within one year 45 115 Net currency swap liabilities e - 4 943 1,332 The movements in the year were as follows: Opening net debt as at 1 January 1,332 1,310 Cash flow before financing activities 513 261 Facility fee capitalised into borrowings - 2 Proceeds from issue of ordinary share capital 7 19 Purchase of treasury shares - 193 Proceeds from own shares 10 4 Equity dividends paid 120 109 Exchange adjustments 21 6 Closing net debt as at 31 December 943 1,332 e Net currency swap liabilities of $nil million 2008 net currency swap liabilities of $4 million comprise $nil million 2008 - $4million of current derivatives within trade and other payables.
24 Smith & Nephew Summary Annual Review 2009 Summary Shareholder Summary Financial Outlook Business Reviews Financial Performance Our Strategy Financial Highlights Introduction Information Statements Remuneration Report Summary Remuneration Report The full Directors Remuneration Report is contained in the 2009 Annual Report at www.
com annualreport Remuneration policy The remuneration policy, as approved by the Remuneration Committee and the Board, is designed to ensure that remuneration is sufficiently competitive to attract, retain and motivate executive directors and executive officers of a calibre that meets the Groups needs to achieve its business objectives.
The policy is designed to ensure that remuneration is firmly linked with the success of the Company and achievement against the Companys key performance indicators.
Remuneration includes base pay and benefits which are referenced to median competitive levels for acceptable performance, and incentive schemes which are designed to motivate and reward for out-performance.
Remuneration packages are benchmarked by reference to appropriate UK and US companies and, where relevant other local markets.
Individual remuneration levels are based on measurable performance against fair and open objectives and there are no automatic pay adjustments unless required by law or local protocol.
The policies described in the full Directors Remuneration Report have been applied throughout 2009.
Whilst it is intended that these policies will continue to apply in 2010 and subsequent years, the Remuneration Committee has an ongoing process for monitoring its policies, including its arrangements for performance based pay, against evolving market practice and relevant guidance.
This is particularly relevant in the current climate.
Where changes are proposed these would only be implemented following a consultation, review and approval process deemed to be appropriate for such change.
Major changes to the remuneration policy are discussed with the Groups principal shareholders.
Performance graph The Companys Total Shareholders Return TSR performance compared to that of the TSR of the FTSE100 index is shown below.
25 Smith & Nephew Summary Annual Review 2009 Summary Shareholder Summary Financial Outlook Business Reviews Financial Performance Our Strategy Financial Highlights Introduction Information Statements Remuneration Report
